- Home
- SBFM vs HLN Comparison
SBFM vs HLN Comparison
Compare SBFM & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- HLN
- Stock Information
- Founded
- SBFM 2006
- HLN 2022
- Country
- SBFM United States
- HLN United Kingdom
- Employees
- SBFM N/A
- HLN N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- HLN Package Goods/Cosmetics
- Sector
- SBFM Health Care
- HLN Consumer Discretionary
- Exchange
- SBFM Nasdaq
- HLN Nasdaq
- Market Cap
- SBFM 4.9M
- HLN 45.6B
- IPO Year
- SBFM N/A
- HLN N/A
- Fundamental
- Price
- SBFM $1.39
- HLN $10.25
- Analyst Decision
- SBFM Strong Buy
- HLN Buy
- Analyst Count
- SBFM 1
- HLN 1
- Target Price
- SBFM $15.00
- HLN $10.95
- AVG Volume (30 Days)
- SBFM 4.4M
- HLN 15.3M
- Earning Date
- SBFM 05-19-2025
- HLN 02-27-2025
- Dividend Yield
- SBFM N/A
- HLN 1.64%
- EPS Growth
- SBFM N/A
- HLN 38.94
- EPS
- SBFM N/A
- HLN 0.20
- Revenue
- SBFM $34,874,283.00
- HLN $14,062,871,660.00
- Revenue This Year
- SBFM $192.48
- HLN $4.78
- Revenue Next Year
- SBFM N/A
- HLN $4.75
- P/E Ratio
- SBFM N/A
- HLN $25.28
- Revenue Growth
- SBFM 44.75
- HLN N/A
- 52 Week Low
- SBFM $1.17
- HLN $8.12
- 52 Week High
- SBFM $33.60
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- SBFM 38.67
- HLN 53.63
- Support Level
- SBFM $1.17
- HLN $10.15
- Resistance Level
- SBFM $1.59
- HLN $10.34
- Average True Range (ATR)
- SBFM 0.16
- HLN 0.19
- MACD
- SBFM 0.04
- HLN 0.03
- Stochastic Oscillator
- SBFM 51.28
- HLN 80.15
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.